About
Corporate Profile
Leadership
Board of Directors
Corporate Presentation
Technology
NaV 1.7
Antiviral Combination
Diseases
CINP
Long Covid
Fibromyalgia
Pipeline
Clinical Trials
CINP 203
Investors
News
News
Investors
Investors
Overview
News
Press Releases
Email Alerts
Events & Presentations
Events
Presentations
Shareholder Letters
Meeting
Governance
Overview
Leadership
Board of Directors
Board Committees
Governance Documents
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Financial & Stock Info
Overview
Quote
Charts
Historical Data
Analyst Coverage
Resources
Overview
IR Contacts
FAQ
Email Alerts
News
Press Releases
Email Alerts
Recent News
View All News
Apr 11, 2025 9:15am EDT
Dogwood Therapeutics, Inc. Receives Nasdaq Confirmation of Compliance
Apr 3, 2025 9:00am EDT
Dogwood Therapeutics, Inc. Regains Nasdaq Compliance
Email Alerts
Sign up for email alerts for Press Releases & SEC Filings
Sign Up
Email Alerts
Contacts
RSS News Feed
